Autres langues Johnson & Johnson

Actions

JNJ

US4781601046

Temps réel estimé Cboe BZX Autres places de cotation 15:47:47 25/04/2024			Varia. 5j.	Varia. 1 janv.
147,3 ^USD	-0,85 %		+2,14 %	-5,03 %

24/04	Le candidat biosimilaire Simponi d'Alvotech montre son efficacité dans l'étude de confirmation	MT
23/04	JOHNSON & JOHNSON : Opinion positive de Daiwa Securities	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset	24/04
Alvotech’s Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study	24/04
Welfare Plan Class Action Litigation Underscores Importance Of Minding Your Fiduciary Duties	24/04
Johnson & Johnson to participate in the Bernstein's 40th Annual Strategic Decisions Conference	23/04
Janssen - CARVYKTI is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy	23/04
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)	22/04
J&J : feu vert de l'UE pour Carvykti dans le myélome multiple	22/04
Johnson & Johnson : CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy	22/04
Contaminated cough syrup in Africa no longer available - WHO	22/04
WHO Likely to Issue Wider Warning About J&J Cough Syrup Contamination, Reuters Reports	19/04
La OMS ve "probable" una alerta más amplia por un jarabe para la tos de J&J contaminado	19/04
WHO says wider alert on contaminated J&J cough syrup 'likely'	19/04
US FDA mandates label updates on CAR-T cancer therapies	19/04
Medical device maker Intuitive beats estimates on strong demand for surgical robots	18/04
Johnson & Johnson : First Quarter 2024 2024 First-Quarter Earnings Transcript	18/04
Johnson & Johnson's Q1 Had 'Some Puts and Takes,' Morgan Stanley Says	17/04
Johnson & Johnson Reports Q1 2024 Results	17/04
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase, Raises Quarterly Dividend by 4.2%	17/04
Planisware: la pequeña estrella francesa del software sale a bolsa, al estilo ninja	17/04
MÄRKTE USA/Uneinheitlich - Powell drosselt Zinssenkungserwartungen	16/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Joseph Wolk, CFO de J&J: Perte d'exclusivité de son médicament phare

Le 23 janvier 2024 à 18:30